These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 11287796)
1. First experiences in combination therapy using olanzapine with SSRIs (citalopram, paroxetine) in delusional depression. König F; von Hippel C; Petersdorff T; Neuhöffer-Weiss M; Wolfersdorf M; Kaschka WP Neuropsychobiology; 2001; 43(3):170-4. PubMed ID: 11287796 [TBL] [Abstract][Full Text] [Related]
2. Paroxetine as antidepressant in combined antidepressant-neuroleptic therapy in delusional depression: observation of clinical use. Wolfersdorf M; Barg T; König F; Leibfarth M; Grünewald I Pharmacopsychiatry; 1995 Mar; 28(2):56-60. PubMed ID: 7624387 [TBL] [Abstract][Full Text] [Related]
3. Quetiapine as combination treatment with citalopram in unipolar depression with prominent somatic symptoms: a randomised, double-blind, placebo-controlled pilot study. Quante A; Regen F; Schindler F; Volkmer K; Severus E; Urbanek C; Luborzewski A; Roepke S; Anghelescu I Psychiatr Danub; 2013 Sep; 25(3):214-20. PubMed ID: 24048387 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Tohen M; Vieta E; Calabrese J; Ketter TA; Sachs G; Bowden C; Mitchell PB; Centorrino F; Risser R; Baker RW; Evans AR; Beymer K; Dube S; Tollefson GD; Breier A Arch Gen Psychiatry; 2003 Nov; 60(11):1079-88. PubMed ID: 14609883 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of olanzapine augmentation of paroxetine therapy in patients with severe body dysmorphic disorder. Nakaaki S; Murata Y; Furukawa TA Psychiatry Clin Neurosci; 2008 Jun; 62(3):370. PubMed ID: 18588607 [No Abstract] [Full Text] [Related]
6. Olanzapine augmentation of paroxetine-refractory obsessive-compulsive disorder. D'Amico G; Cedro C; Muscatello MR; Pandolfo G; Di Rosa AE; Zoccali R; La Torre D; D'Arrigo C; Spina E Prog Neuropsychopharmacol Biol Psychiatry; 2003 Jun; 27(4):619-23. PubMed ID: 12787848 [TBL] [Abstract][Full Text] [Related]
7. [Effective treatment of depressive disorder with psychotic symptoms by olanzapine combination therapy]. Schmitt A; Braus DF Dtsch Med Wochenschr; 2000 Dec; 125(50):1526-9. PubMed ID: 11190762 [TBL] [Abstract][Full Text] [Related]
8. [Olanzapine in the treatment of depressive disorders with psychotic symptoms]. Adli M; Rossius W; Bauer M Nervenarzt; 1999 Jan; 70(1):68-71. PubMed ID: 10087520 [TBL] [Abstract][Full Text] [Related]
9. Pharmacotherapy of delusional depression: experience with combinations of antidepressants with the neuroleptics zotepine and haloperidol. Wolfersdorf M; König F; Straub R Neuropsychobiology; 1994; 29(4):189-93. PubMed ID: 7914009 [TBL] [Abstract][Full Text] [Related]
10. Olanzapine-induced retarded ejaculation: role of paroxetine comedication? A case report. Bizouard P; Vandel S; Kantelip JP Therapie; 2001; 56(4):443-5. PubMed ID: 11677871 [No Abstract] [Full Text] [Related]
11. Clinical application of paroxetine for tapering benzodiazepine use in non-major-depressive outpatients visiting an internal medicine clinic. Nakao M; Takeuchi T; Nomura K; Teramoto T; Yano E Psychiatry Clin Neurosci; 2006 Oct; 60(5):605-10. PubMed ID: 16958945 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and tolerability of Paroxetine 20 mg daily in the treatment of depression and depression associated anxiety. Chaudhry HR; Qureshi Z; Tareen IA; Yazdani I J Pak Med Assoc; 2002 Nov; 52(11):518-25. PubMed ID: 12585372 [TBL] [Abstract][Full Text] [Related]
13. Patterns of symptom improvement during antidepressant treatment of delusional depression. Serretti A; Lattuada E; Zanardi R; Franchini L; Smeraldi E Psychiatry Res; 2000 May; 94(2):185-90. PubMed ID: 10808044 [TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care. Wade A; Crawford GM; Angus M; Wilson R; Hamilton L Int Clin Psychopharmacol; 2003 May; 18(3):133-41. PubMed ID: 12702891 [TBL] [Abstract][Full Text] [Related]
15. Co-administration of citalopram and clozapine: effect on plasma clozapine levels. Taylor D; Ellison Z; Ementon Shaw L; Wickham H; Murray R Int Clin Psychopharmacol; 1998 Jan; 13(1):19-21. PubMed ID: 9988363 [TBL] [Abstract][Full Text] [Related]
16. [Pharmacological treatment of delusional depression]. Amore M; Giordani L; Giorgetti G; Zazzeri N Minerva Psichiatr; 1996 Mar; 37(1):29-33. PubMed ID: 8804200 [TBL] [Abstract][Full Text] [Related]
17. Addition of olanzapine for treatment-resistant depression. Pitchot W; Ansseau M Am J Psychiatry; 2001 Oct; 158(10):1737-8. PubMed ID: 11579017 [No Abstract] [Full Text] [Related]
18. Outcome in delusional depression comparing trimipramine monotherapy with a combination of amitriptyline and haloperidol--a double-blind multicenter trial. Künzel HE; Ackl N; Hatzinger M; Held K; Holsboer-Trachsler E; Ising M; Kaschka W; Kasper S; Konstantinidis A; Sonntag A; Uhr M; Yassouridis A; Holsboer F; Steiger A J Psychiatr Res; 2009 Apr; 43(7):702-10. PubMed ID: 19038406 [TBL] [Abstract][Full Text] [Related]
19. Fluvoxamine alone in the treatment of delusional depression. Gatti F; Bellini L; Gasperini M; Perez J; Zanardi R; Smeraldi E Am J Psychiatry; 1996 Mar; 153(3):414-6. PubMed ID: 8610832 [TBL] [Abstract][Full Text] [Related]
20. Melancholic symptoms during concurrent olanzapine and fluoxetine. Nelson LA; Swartz CM Ann Clin Psychiatry; 2000 Sep; 12(3):167-70. PubMed ID: 10984007 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]